CFTR modulators: transformative therapies for cystic fibrosis.

Area of Science:

• Biomedical Research
• Drug Development

Background:

• The Cystic Fibrosis Foundation (CFF) plays a role in advancing treatments for cystic fibrosis.
• Development of CFTR modulators is crucial for managing cystic fibrosis.

Purpose of the Study:

• To disclose the Cystic Fibrosis Foundation's involvement in the development of CFTR modulators.
• To outline the nature of agreements related to therapeutic development.

Main Methods:

• Review of CFF's employment and contractual relationships.
• Analysis of CFF's engagement in therapeutic development award and licensing agreements.

Main Results:

• Authors are employed by CFF.
• CFF has entered into agreements for CFTR modulator development.
• These agreements may lead to intellectual property rights and royalties for CFF.

Conclusions:

• CFF is actively engaged in the development of CFTR modulators.
• Confidentiality restrictions prevent detailed disclosure of specific agreements.